M&A
Suntory, Tilaknagar Industries in race to buy Imperial Spirits
24 Apr 2014
Japan's second-largest brewing and distilling company Suntory Holdings and Mansion House brandy maker Tilaknagar Industries, are in the race to buy Coimbatore-based Imperial Spirits
GE in talks to buy Alstom SA for $13 bn
24 Apr 2014
General Electric Co (GE) is in talks to buy French power equipment and rail infrastructure giant Alstom SA for about $13 billion
GE in talks to buy Alstom SA for $13 bn
24 Apr 2014
General Electric Co (GE) is in talks to buy French power equipment and rail infrastructure giant Alstom SA for about $13 billion
GE in talks to buy Alstom SA for $13 bn
24 Apr 2014
General Electric Co (GE) is in talks to buy French power equipment and rail infrastructure giant Alstom SA for about $13 billion
Deepak Fertilisers to make open offer for 26% stake of Mangalore Chemicals
23 Apr 2014
The acquisition will raise Deepak Fertilisers' stake in Mangalore Chemicals to 26.1 per cent, obliging it launch an open offer for buying at least 26 per cent from the public
Cognizant acquires US digital video solutions company, Itaas
23 Apr 2014
The acquisition will enable Cognizant to capitalise on the growing demand for greater interactivity, higher personalisation, and innovative content delivery in the multi-screen and video market
Valeant tables hostile $45.7 bn bid for Botox maker Allergan
23 Apr 2014
Valeant Pharmaceuticals International Inc, Canada's biggest drug maker and one of the most aggressive acquirers, yesterday tabled a hostile $45.7-billion cash and stock bid for Botox maker Allergan Inc
European regulator approves Suntory's $13.6-bn Beam deal
22 Apr 2014
In recent years, Suntory has been making acquisitions and developing business partnerships with major beverage companies in a bid to rapidly expand its global footprint
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 Apr 2014
Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 Apr 2014
Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 Apr 2014
Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.
Valeant teams up with hedge fund to buy Botox maker Allergan for $42 bn
22 Apr 2014
News of the impending bid sent the stock price of Valeant and Allergan companies soaring in after-hours trading
Pfizer weighs $101-bn bid for AstraZeneca
21 Apr 2014
A potential deal with AstraZeneca would be the biggest-ever acquisition in the pharmaceutical industry, and would see another iconic British brand being acquired by a foreign company
Pfizer weighs $101-bn bid for AstraZeneca
21 Apr 2014
A potential deal with AstraZeneca would be the biggest-ever acquisition in the pharmaceutical industry, and would see another iconic British brand being acquired by a foreign company
Pfizer weighs $101-bn bid for AstraZeneca
21 Apr 2014
A potential deal with AstraZeneca would be the biggest-ever acquisition in the pharmaceutical industry, and would see another iconic British brand being acquired by a foreign company